LexaMed Expands Growth-Chek Product Line

LexaMed is pleased to announce an addition to our BEC Growth-ChekTM Microbial Suspension product line: Staphylococcus aureus. S. aureus is a Gram-positive coccus that has recently been specified as a required challenge organism for USP growth promotion evaluations. Read more

LexaMed Receives ISO 13485:2003 Certification

LexaMed Ltd., a provider of contract laboratory and consulting services to the medical device, pharmaceutical industries and related industries, announced today that it had received ISO 13485:2003 certification from SAI Global, an internationally known Notified Body registration firm. Read more